This content is from: Canada
UPDATE-Tax Court of Canada rejects Glaxo Canada transfer pricing appeal
GlaxoSmithKline has lost an appeal in the Tax Court of Canada over a reassessment of its tax liability on supplier transactions in the early 1990s
To access our market-driven intelligence please request a trial here.
Read this article – and more – for a 30 day period.
REQUEST ACCESSAre you already an ITR subscriber? Log in here